Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jonathan Swerdlin
AddedMar 31, 2024
UpdatedMay 31, 2026
Jonathan Swerdlin

Jonathan Swerdlin

Co-Founder, Wisdom VC

CrunchbaseLinkedIn

Jonathan Swerdlin's Career

Wisdom VC
Wisdom VC

San Francisco, CA, US

Co-Founder
Function Health
Function Health

Los Angeles, CA, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jonathan Swerdlin's Career

Wisdom VC
Wisdom VC
Investment Firm72016San Francisco, CA, US
Co-Founder

Leadership at Wisdom VC

joshua kauffmanjoshua kauffmanCo-Founder
Function Health
Function Health
Seed$3M252021Los Angeles, CA, US
CEO· C-Suite · Management

Recent news

Whoop opens blood-testing service to what it says is a 350,000-person waitlistTechCrunch · 2025

Leadership at Function Health

Mike NemkeMike NemkeCo-Founder & CTO
Pranitha PatilPranitha PatilCo-Founder & COO
Mike NemkeMike NemkeCo-Founder
Pranitha PatilPranitha PatilCo-Founder

Similar to Function Health

GProvGProvSan Francisco, CA, USest. 2021GProvSan Francisco, CA, US · est. 2021

GProv is the AI health navigator for expats and travellers in 20+ countries.

5
SuperpowerSuperpowerSan Francisco, CA, USBiomarker Testingest. 2023SuperpowerSan Francisco, CA, US · est. 2023

Superpower provides comprehensive biomarker testing and AI-powered longevity protocols for proactive health management.

Series A · $34M166
Heads Up HealthHeads Up HealthScottsdale, AZ, USAnalytics, Health Dataest. 2014Heads Up HealthScottsdale, AZ, US · est. 2014

Data analytics platform providing customizable health dashboards for individuals and healthcare professionals.

Seed · $3.1M42
InsideTrackerInsideTrackerCambridge, MA, USHealth Analysisest. 2009InsideTrackerCambridge, MA, US · est. 2009

InsideTracker: Optimizing personal health for longevity and vitality from the inside out.

Series B · $18.2M101

People Similar to Jonathan Swerdlin

Willix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakHaeil YiHaeil YiCo-Founder · DunamuChi-hyung SongChi-hyung SongCo-Founder · DunamuLee Sirg-OoLee Sirg-OoCEO · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialRaj ParekhRaj ParekhCo-Founder & CEO · PortalCharlie HipwoodCharlie HipwoodFounder · Stag IndustrialKirk ChisholmKirk ChisholmFounder · PortalAaron BonserAaron BonserCo-Founder · VenturelabJeff CherryJeff CherryCo-Founder · Conscious Venture LabDanny LaironDanny LaironCo-Founder · Mission Labs